Irinotecan and Panitumumab as 3rd Line Treatment for mCRC Without KRAS Mutations
This study has been completed.
Sponsor:
Vejle Hospital
Information provided by (Responsible Party):
Vejle Hospital
ClinicalTrials.gov Identifier:
NCT00792363
First received: November 14, 2008
Last updated: June 12, 2012
Last verified: June 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | August 2011 |
| Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |